India, New Zealand to sign FTA on April 27; aim to double bilateral trade
India's pharmaceutical and medical devices sectors are expected to benefit from faster regulatory approvals in New Zealand through the acceptance of GMP (Good Manufacturing Practice) and GCP (Good Clinical Practice) inspection reports from recognised regulators, including the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the UK's Medicines and Healthcare products Regulatory Agency (MHRA).
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
